| Puppyroach said: Well, where I live it´s quite common with research in both the public and the private sector and the government buys the medicines to sell to citizens. Some medicine is quite expensive but we have a high-cost safety net where you nver pay more than approx. 265$ per year for medicine. And we still manage to have way lower expenses per capita for healthcare with a better healthcare outcome than the US. So there must be something about our model that just works =). |
What exactly is this "high-cost safety net" that you speak of ? Healthcare outcomes are more than just drug prices ...
$265 per capita is only enough to cover the R&D expenses of pharma companies in the US. Does that "something" about your nation's model includes the US being a sacrificial lamb ? If so how would that help them since they're the ones being used already ? Should big pharma in the US just pass the cost of development to Europe instead ? 
You should be fortunate enough that your fragile model isn't facing a trade war where your nation would lose access to the most modern foreign developed medicine like how China is experiencing a crisis in their IT industry since their access to US semiconductor technology has been circumvented ...
I assume that your nation simply doesn't see the value in having a independent technology sector which is a shame since your success will be entirely hinged upon if you guys cross roads with the US or not ... (with the UK leaving the EU, you now face more disunity than ever in a big and growing industry where a couple big players like the UK and Switzerland are fading from your picture)
Having said all of that what exactly is your nation's biggest contribution to the global pharmaceutical industry ?
